BioReference will broaden availability of serological antibody tests to states, hospitals and healthcare organizations throughout the United States ELMWOOD PARK, N.J., April 29, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced that beginning today it will offer antibody blood tests to detect an immune response after infection with the COVID-19 virus. Antibody testing […]
Tag Archives: Coronavirus
Press Release
OPKO Health’s BioReference Laboratories Partners with Hospitals Nationwide to Provide Prioritized Testing to Inpatients with Suspected Coronavirus Disease 2019 (COVID-19)
06
Apr
Apr
ELMWOOD PARK, N.J., April 6, 2020 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced that it will continue to prioritize COVID-19 testing for hospital inpatients and critically ill patients around the country. “Our goal is to maintain the current 24 hour turnaround time for these patients,” said Jon R. Cohen, M.D., Executive Chairman of […]
02
Apr
Apr
The 2019 novel coronavirus disease (COVID-19) is a virus of global health significance caused by infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). On March 11, 2020, the World Health Organization (WHO) declared COVID-19 a global pandemic. How is it Transmitted? According to the US Centers for Disease Control and Prevention (CDC), COVID-19 is […]
Press Release
OPKO Health’s BioReference Laboratories and City of Miami Provide Testing for Coronavirus Disease 2019 (COVID-19)
24
Mar
Mar
BioReference will offer COVID-19 testing for public drive-through facilities for Miami residents and Larkin Community Hospital ELMWOOD PARK, N.J., March 24, 2020 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a collaboration with the City of Miami to provide coronavirus disease 2019 (COVID-19) testing. BioReference will provide COVID-19 testing at drive-through locations […]
Press Release
OPKO Health’s BioReference Laboratories Offers Testing for Coronavirus Disease 2019 (COVID-19)
13
Mar
Mar
In partnership with NY State Department of Health, BioReference will provide COVID-19 testing for the first public drive-through testing facility on the East Coast COVID-19 tests now available for use by healthcare providers throughout the US ELMWOOD PARK, N.J., March 13, 2020 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), is now […]
Press Release
OPKO Health’s BioReference Laboratories to Introduce Coronavirus Disease (COVID-19) Test
05
Mar
Mar
COVID-19 test will aid healthcare professionals and public health authorities to identify patients infected with COVID-19 ELMWOOD PARK, N.J., March 05, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced it will offer a test for the novel coronavirus (2019-nCoV), a contagious virus that causes respiratory infection and has shown evidence of human-to-human […]
ACLA Statement on COVID-19 Testing STATEMENT FROM ACLA PRESIDENT JULIE KHANI: “We appreciated the opportunity to meet with Vice President Pence and members of the White House’s Coronavirus Task Force this afternoon on the critical issues related to testing capacity. As an industry, clinical labs have taken steps to meet the growing demand for national […]
- 1
- 2
